Understanding CD4+ T cells in autoimmune bullous diseases

被引:6
作者
Lee, A. Yeong [1 ,2 ]
Kim, Taehee [1 ,2 ]
Kim, Jong Hoon [1 ,2 ]
机构
[1] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Dermatol, Seoul, South Korea
[2] Yonsei Univ, Gangnam Severance Hosp, Cutaneous Biol Res Inst, Coll Med, Seoul, South Korea
关键词
autoimmune bullous disease; pemphigus; bullous pemphigoid; pathogenicity; CD4 T cells; DOUBLE-BLIND TRIAL; PEMPHIGUS-VULGARIS; DESMOGLEIN; 3; INTRAVENOUS IMMUNOGLOBULIN; ACTIVE DISEASE; PIVOTAL ROLE; AUTOANTIBODIES; RITUXIMAB; AUTOANTIGEN; EPITOPES;
D O I
10.3389/fimmu.2023.1161927
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune bullous diseases (AIBDs) are a group of life-threatening blistering diseases caused by autoantibodies that target proteins in the skin and mucosa. Autoantibodies are the most important mediator in the pathogenesis of AIBDs, and various immune mechanisms contribute to the production of these pathogenic autoantibodies. Recently, significant progress has been made in understanding how CD4(+) T cells drive autoantibody production in these diseases. Here, we review the critical role of CD4(+) T cells in the production of pathogenic autoantibodies for the initiation and perpetuation of humoral response in AIBDs. To gain an in-depth understanding of CD4(+) T-cell pathogenicity, antigen specificity, and mechanisms of immune tolerance, this review covers comprehensive mouse and human studies of pemphigus and bullous pemphigoid. Further exploration of pathogenic CD4(+) T cells will potentially provide immune targets for improved treatment of AIBDs.
引用
收藏
页数:8
相关论文
共 79 条
[31]   Targeting inducible costimulator expressed on CXCR5+PD-1+ TH cells suppresses the progression of pemphigus vulgaris [J].
Kim, A. Reum ;
Han, Dawoon ;
Choi, Ji Young ;
Seok, Joon ;
Kim, Song-Ee ;
Seo, Seong-Hoon ;
Takahashi, Hayato ;
Amagai, Masayuki ;
Park, Su-Hyung ;
Kim, Soo-Chan ;
Shin, Eui-Cheol ;
Kim, Jong Hoon .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (05) :1070-+
[32]   Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients [J].
Kim, J. H. ;
Kim, Y. H. ;
Kim, M. R. ;
Kim, S. -C. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) :646-651
[33]   Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa [J].
Kim, Jong Hoon ;
Kim, Soo-Chan .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[34]   Long-Term Prognosis of Pemphigus in Korea: Retrospective Analysis of 199 Patients [J].
Kim, Mi Ri ;
Kim, Hyeon Chang ;
Kim, Soo-Chan .
DERMATOLOGY, 2011, 223 (02) :182-188
[35]   BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid [J].
Kobayashi, M ;
Amagai, M ;
Kuroda-Kinoshita, K ;
Hashimoto, T ;
Shirakata, Y ;
Hashimoto, K ;
Nishikawa, T .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2002, 30 (03) :224-232
[36]   Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase-4 Inhibitor vs Second-generation Sulfonylurea [J].
Lee, Hemin ;
Chung, Hye Jin ;
Pawar, Ajinkya ;
Patorno, Elisabetta ;
Kim, Dae Hyun .
JAMA DERMATOLOGY, 2020, 156 (10) :1107-1114
[37]   Follicular Helper T Cells (Tfh) and IL-21 Involvement in the Pathogenesis of Bullous Pemphigoid [J].
Li, Qiuju ;
Liu, Zhenfeng ;
Dang, Erle ;
Jin, Liang ;
He, Zheng ;
Yang, Luting ;
Shi, Xiaowei ;
Wang, Gang .
PLOS ONE, 2013, 8 (07)
[38]   Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain [J].
Lin, MS ;
Fu, CL ;
Giudice, GJ ;
Olague-Marchan, M ;
Lazaro, AM ;
Stastny, P ;
Diaz, LA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (06) :955-961
[39]   Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris [J].
Lin, MS ;
Swartz, SJ ;
Lopez, A ;
Ding, X ;
FernandezVina, MA ;
Stastny, P ;
Fairley, JA ;
Diaz, LA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (01) :31-40
[40]   Paraneoplastic pemphigus is associated with the DRB1*03 allele [J].
Martel, P ;
Loiseau, P ;
Joly, P ;
Busson, M ;
Lepage, V ;
Mouquet, H ;
Courville, P ;
Flageul, B ;
Charron, D ;
Musette, P ;
Gilbert, D ;
Tron, F .
JOURNAL OF AUTOIMMUNITY, 2003, 20 (01) :91-95